Ginkgo biloba supplements from Pharma Nord demonstrates antioxidant and anti-inflammatory properties. Ginkgo biloba benefits may include maintaining good blood circulation, supporting cognitive functions (such as memory, recall and processing) and helping protect the cells, including the brain cells from oxidative stress. Also known as the maidenhair tree, Ginkgo biloba is one of the oldest living plants and has been used to treat medical conditions for thousands of years. Bio-Biloba from Pharma Nord is the only ginkgo biloba supplement available in the UK with a Traditional Herbal Remedy (THR) licence from medicines watchdog the MHRA for the treatment of symptoms of Raynaud’s Phenomenon and tinnitus. This means that you can be assured of its quality and safety as a traditional herbal product for use in Raynaud’s and tinnitus, based upon long-standing use as a traditional remedy. Key Notes Ginkgo biloba demonstrates antioxidant and anti-inflammatory properties. Ginkgo biloba benefits may include: Maintaining good blood circulation Tackling symptoms of Raynaud’s Phenomenon (based on use as a traditional remedy) Tackling symptoms of tinnitus (based on use as a traditional remedy) Supporting cognitive and memory functions (such as memory recall and processing) Protect cells, including brain cells, from oxidative stress Ingredients Ginkgo biloba extract 100mg of which ginkgo flavone- glycosides comprise 24mgterpene lactones 6mg Other Ingredients: Microcrystalline celluloseTalcSilicon dioxideMagnesium stearateHydroxypropyl methyl celluloseTitanium dioxid Directions For UseTake 1-2 tablets per day, or as directed by a physician. PrecautionsThere are many Ginkgo biloba benefits and the Ginkgo biloba plant, or maidenhair tree has been used safely for medical purposes for centuries. However, you should use Ginkgo biloba supplements with caution if you are taking prescribed anticoagulant medication such as clopidogrel (Plavix), or dipyridamole (Persantin). Ginkgo biloba supplements may also cause gastrointestinal disturbances and headaches in susceptible individuals.
